Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01862081
Title A Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Age Groups: adult
Covered Countries USA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Florida Cancer Specialists - Tampa (Dr. MLK Blvd) Tampa Florida 33607 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Texas Oncology, P.A; Baylor Sammons Cancer Center Dallas Texas 75231 United States Details
Texas Oncology, P.A. - Fort Worth Fort Worth Texas 76104 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 United States Details
UZ Leuven; Maag, -darm en leverziekten/endoscopie - Endoscopy Leuven 3000 Belgium Details
Princess Margaret Hospital Toronto Ontario M4X 1K9 Canada Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from for the field